Cargando…

The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective

BACKGROUND: Nephrotic syndrome is a disorder characterized by proteinuria, hypoalbuminemia and dyslipidemia. Low-dose alternate-day steroid regimen is the standard of care. In case of relapse or significant adverse events, steroid-sparing agents may be used. This analysis was aimed at assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maratea, Dario, Bettio, Monica, Corti, Maria Grazia, Montini, Giovanni, Venturini, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943005/ https://www.ncbi.nlm.nih.gov/pubmed/27405390 http://dx.doi.org/10.1186/s13052-016-0271-6

Ejemplares similares

The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
por: Zhao, Zhihong, et al.
Publicado: (2015)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019)

Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It’s All in the Timing
por: Qader, Md Abdul, et al.
Publicado: (2023)

Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea
por: Ahn, Yo Han, et al.
Publicado: (2018)

Targeting Tubulointerstitium to Predict Kidney Outcomes in Childhood Nephrotic Syndrome
por: Azukaitis, Karolis, et al.
Publicado: (2020)

The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis
por: Liu, Sidi, et al.
Publicado: (2021)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
por: Kim, Ji Hyun, et al.
Publicado: (2017)

Rituximab Treatment for Nephrotic Syndrome in Children
por: Iijima, Kazumoto, et al.
Publicado: (2014)

Effectiveness of rituximab in nephrotic syndrome treatment
por: Popko, Katarzyna, et al.
Publicado: (2017)

Using Existing Mobile Technology to Monitor Disease Activity: An Example in Childhood Nephrotic Syndrome
por: Eaton, Cyd K.
Publicado: (2019)

Rituximab Use for the Treatment of Childhood Nephrotic Syndrome by Canadian Pediatric Nephrologists: A National Survey
por: Meeuwisse, Cory, et al.
Publicado: (2022)

Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center
por: Gomes, Rita, et al.
Publicado: (2022)

Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
por: Hogan, Julien, et al.
Publicado: (2020)

Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
por: Morello, William, et al.
Publicado: (2019)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
por: Topaloğlu, Rezan, et al.
Publicado: (2019)

Rituximab treatment for difficult-to-treat nephrotic syndrome in children:a multicenter, retrospective study
por: TAŞDEMİR, Mehmet, et al.
Publicado: (2021)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris
por: Croitoru, David O., et al.
Publicado: (2023)

Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome
por: Basu, Biswanath, et al.
Publicado: (2023)

Extracorporeal Therapy for Idiopathic Nephrotic Syndrome
por: Au, Eric, et al.
Publicado: (2021)

The outcome of rituximab in treating steroid dependent nephrotic syndrome.: Histopathology and immunosuppressive drugs as predicting factors
por: Al Salloum, Abdullah A., et al.
Publicado: (2022)

Physician‒Scientists in Italian Dermatology: Hurdles and Perspectives
por: Pincelli, Carlo, et al.
Publicado: (2021)

Successful Pregnancies in a Patient with Childhood-onset Steroid-dependent Nephrotic Syndrome during Rituximab Maintenance Therapy
por: Nara, Mizuho, et al.
Publicado: (2021)

Novel coronavirus (COVID-19) pneumonia: Portable chest X-ray or computed tomography? An Italian perspective
por: Mazzei, Maria Antonietta, et al.
Publicado: (2021)

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

Commentary: Rituximab in scleritis
por: Dutta Majumder, Parthopratim
Publicado: (2020)

Rituximab in idiopathic nephrotic syndrome: still waiting for stronger evidences
por: Belangero, Vera Maria Santoro
Publicado: (2023)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
por: Guzzi, Francesco, et al.
Publicado: (2020)

Adjusting the Lens: Real World Outcomes in Nephrotic Syndrome
por: Castledine, Clare, et al.
Publicado: (2020)

Nephrotic-range Albuminuria as the presenting symptom of Dent-2 disease
por: De Mutiis, Chiara, et al.
Publicado: (2015)

Urinary indices in nephrotic syndrome
por: Sahay, M.
Publicado: (2011)

Acquired Hemophilia A Successfully Treated with Rituximab
por: D’Arena, Giovanni, et al.
Publicado: (2015)

Efficacy and safety of levamisole in childhood nephrotic syndrome: A meta-analysis
por: Bhatt, Girish Chandra, et al.
Publicado: (2023)

The Diagnostic Journey of Childhood Idiopathic Nephrotic Syndrome: Perspectives of Children and Their Caregivers
por: Okpere, Augustina, et al.
Publicado: (2022)

Hypertension in Childhood Nephrotic Syndrome
por: Shatat, Ibrahim F., et al.
Publicado: (2019)

Pediatric febrile urinary tract infections: the current state of play
por: Hewitt, Ian K, et al.
Publicado: (2011)

Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome
por: Counsilman, Clare E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bm3bvhahvh5vt3ipvm09tfjotc